RJA
COV

Raymond James & Associates’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Raymond James & Associates’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,700
Closed -$220K – 2317
2014
Q2 		$220K Buy
+13,700
New +$1.02M ﹤0.01% 2142

Raymond James & Associates's COV Position: Q1 2015 in Review

Raymond James & Associates sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 183,294 shares — an estimated $18.7M sold.

Raymond James & Associates first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $22.1M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Raymond James & Associates reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Raymond James & Associates sold 183,294 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $18.7M.
  • Raymond James & Associates first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Raymond James & Associates's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $22.1M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Raymond James & Associates's 13F filing for Q1 2015, filed 28 Apr 2015.